ATE483716T1 - Lösungsmittelfreies amorphes rapamycin - Google Patents
Lösungsmittelfreies amorphes rapamycinInfo
- Publication number
- ATE483716T1 ATE483716T1 AT05792296T AT05792296T ATE483716T1 AT E483716 T1 ATE483716 T1 AT E483716T1 AT 05792296 T AT05792296 T AT 05792296T AT 05792296 T AT05792296 T AT 05792296T AT E483716 T1 ATE483716 T1 AT E483716T1
- Authority
- AT
- Austria
- Prior art keywords
- free
- solvent
- amorphic
- rapamycin
- therapeutic agents
- Prior art date
Links
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 title 1
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 title 1
- 229960002930 sirolimus Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 3
- 229940124597 therapeutic agent Drugs 0.000 abstract 3
- 239000011248 coating agent Substances 0.000 abstract 2
- 238000000576 coating method Methods 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60532404P | 2004-08-27 | 2004-08-27 | |
| PCT/US2005/030606 WO2006026531A1 (en) | 2004-08-27 | 2005-08-24 | Solvent free amorphous rapamycin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE483716T1 true ATE483716T1 (de) | 2010-10-15 |
Family
ID=35539393
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05792296T ATE483716T1 (de) | 2004-08-27 | 2005-08-24 | Lösungsmittelfreies amorphes rapamycin |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US7393952B2 (de) |
| EP (1) | EP1781672B1 (de) |
| JP (1) | JP5117190B2 (de) |
| AT (1) | ATE483716T1 (de) |
| CA (1) | CA2578245C (de) |
| DE (1) | DE602005024012D1 (de) |
| WO (1) | WO2006026531A1 (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8715771B2 (en) * | 2003-02-26 | 2014-05-06 | Abbott Cardiovascular Systems Inc. | Coated stent and method of making the same |
| US7255891B1 (en) * | 2003-02-26 | 2007-08-14 | Advanced Cardiovascular Systems, Inc. | Method for coating implantable medical devices |
| JP2007505932A (ja) | 2003-09-18 | 2007-03-15 | マクサイト, インコーポレイテッド | 経強膜送達 |
| US8663639B2 (en) | 2005-02-09 | 2014-03-04 | Santen Pharmaceutical Co., Ltd. | Formulations for treating ocular diseases and conditions |
| CA2597590A1 (en) | 2005-02-09 | 2006-08-17 | Macusight, Inc. | Formulations for ocular treatment |
| KR101478164B1 (ko) * | 2006-02-09 | 2014-12-31 | 산텐 세이야꾸 가부시키가이샤 | 안정한 제제와 그 제조 및 사용 방법 |
| AU2007230964B2 (en) | 2006-03-23 | 2012-07-19 | Santen Pharmaceutical Co., Ltd. | Formulations and methods for vascular permeability-related diseases or conditions |
| US20090011117A1 (en) * | 2007-07-03 | 2009-01-08 | Endotronix, Inc. | Methods for texturing a surface of an endovascular implant |
| EP2676687A1 (de) | 2008-06-25 | 2013-12-25 | Boston Scientific Scimed, Inc. | Medizinische Vorrichtungen mit therapeutischen Mitteln |
| IT1400977B1 (it) | 2010-07-01 | 2013-07-05 | Euticals Spa | Nuovi complessi di inclusione farmaceutici, solidi, solubili in acqua e le loro soluzioni acquose per uso orale, oftalmico, topico o parenterale, contenenti un macrolide ed alcune ciclodestrine. |
| US10172789B2 (en) | 2013-01-24 | 2019-01-08 | Palvella Therapeutics Llc | Compositions for transdermal delivery of mTOR inhibitors |
| JP6472155B2 (ja) * | 2013-04-01 | 2019-02-20 | テルモ株式会社 | ステントおよびステントデリバリーシステム |
| WO2015181826A1 (en) | 2014-05-27 | 2015-12-03 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Crystalline coating and release of bioactive agents |
| CA2998170C (en) | 2015-09-15 | 2023-10-03 | Savage Medical, Inc. | Devices and methods for anchoring a sheath in a tissue cavity |
| WO2018129364A1 (en) | 2017-01-06 | 2018-07-12 | Palvella Therapeutics Llc | Anhydrous compositions of mtor inhibitors and methods of use |
| CN108129490B (zh) * | 2017-12-11 | 2020-12-01 | 成都海创药业有限公司 | 一种制备依维莫司无定形固体的方法 |
| EP3817743A4 (de) | 2018-07-02 | 2022-07-06 | Palvella Therapeutics, Inc. | Wasserfreie zusammensetzungen von mtor-hemmern und verfahren zur verwendung |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA737247B (en) * | 1972-09-29 | 1975-04-30 | Ayerst Mckenna & Harrison | Rapamycin and process of preparation |
| GB9221220D0 (en) | 1992-10-09 | 1992-11-25 | Sandoz Ag | Organic componds |
| FR2736550B1 (fr) | 1995-07-14 | 1998-07-24 | Sandoz Sa | Composition pharmaceutique sous la forme d'une dispersion solide comprenant un macrolide et un vehicule |
| US6384213B1 (en) | 1998-10-23 | 2002-05-07 | Ranbaxy Laboratories Limited | Process for preparing a pure, pharmacopoeial grade amorphous form of cefuroxime axetil |
| WO2002057228A1 (en) | 2001-01-17 | 2002-07-25 | Biocon India Limited | Atorvastatin calcium |
| JP4270549B2 (ja) * | 2002-04-22 | 2009-06-03 | 財団法人乙卯研究所 | 血管性疾患の治療のための医薬 |
| WO2004026174A2 (en) * | 2002-09-20 | 2004-04-01 | Conor Medsystems, Inc. | Expandable medical device with openings for delivery of multiple beneficial agents |
| DE10244847A1 (de) * | 2002-09-20 | 2004-04-01 | Ulrich Prof. Dr. Speck | Medizinische Vorrichtung zur Arzneimittelabgabe |
| US20040093064A1 (en) * | 2002-11-12 | 2004-05-13 | Gjalt Bosma | Drug eluting stent graft combination |
| KR20060052880A (ko) | 2003-07-25 | 2006-05-19 | 와이어쓰 | 동결건조된 cci- 779 제형 |
| EP1660081A1 (de) | 2003-09-03 | 2006-05-31 | Wyeth | Amorphe rapamycin 42-ester mit 3-hydroxy-2-(hydroxymethyl)-2-methylpropionsäure und diese enthaltende pharmazeutische zusammensetzungen |
-
2005
- 2005-08-24 CA CA2578245A patent/CA2578245C/en not_active Expired - Fee Related
- 2005-08-24 WO PCT/US2005/030606 patent/WO2006026531A1/en not_active Ceased
- 2005-08-24 EP EP05792296A patent/EP1781672B1/de not_active Expired - Lifetime
- 2005-08-24 US US11/210,393 patent/US7393952B2/en not_active Expired - Lifetime
- 2005-08-24 DE DE602005024012T patent/DE602005024012D1/de not_active Expired - Lifetime
- 2005-08-24 AT AT05792296T patent/ATE483716T1/de not_active IP Right Cessation
- 2005-08-24 JP JP2007530211A patent/JP5117190B2/ja not_active Expired - Fee Related
-
2008
- 2008-05-27 US US12/127,467 patent/US20080227982A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20060128739A1 (en) | 2006-06-15 |
| CA2578245C (en) | 2013-10-29 |
| JP2008511642A (ja) | 2008-04-17 |
| US20080227982A1 (en) | 2008-09-18 |
| US7393952B2 (en) | 2008-07-01 |
| EP1781672A1 (de) | 2007-05-09 |
| EP1781672B1 (de) | 2010-10-06 |
| CA2578245A1 (en) | 2006-03-09 |
| WO2006026531A1 (en) | 2006-03-09 |
| DE602005024012D1 (de) | 2010-11-18 |
| JP5117190B2 (ja) | 2013-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602005024012D1 (de) | Lösungsmittelfreies amorphes rapamycin | |
| NO20073065L (no) | Injiserbare nanopartikulaere olanzapinformuleringer | |
| NO20083002L (no) | Fremgangsmate for anvendelse av CD40-bindende forbindelser | |
| TW200738725A (en) | Unsaturated mTOR inhibitors | |
| TW200740815A (en) | P38 MAP kinase inhibitors and methods for using the same | |
| CR8744A (es) | Compuestos terapeuticos | |
| TW200801006A (en) | Fused bicyclic mTOR inhibitors | |
| IL177483A0 (en) | Means for transdermal administration of nicotine | |
| TW200740776A (en) | N-phenylbenzotriazolyl c-kit inhibitors | |
| UY29246A1 (es) | Nuevos compuestos | |
| TW200519111A (en) | N3-substituted imidazopyridine C-KIT inhibitors | |
| MX2012002528A (es) | Agente terapeutico para trastornos del estado de animo. | |
| BRPI0415164A (pt) | dispositivo para administrar uma composição bioterapêutica, composição bioterapêutica, método de preparação de uma composição bioterapêutica, método de tratamento, e dispensador | |
| GB0416508D0 (en) | Therapeutic agents | |
| NO20072832L (no) | Smertestillende middel | |
| EA200700766A1 (ru) | Способ получения производных [1,4,5]-оксадиазепина | |
| MX2010001303A (es) | Compuestos terapeuticos. | |
| EP2231264A1 (de) | Verfahren zur abgabe von sirna durch iontophorese | |
| TW200619205A (en) | A method for preparing irbesartan and intermediates thereof | |
| MX2008010804A (es) | Derivados de rapamicina para tratar neuroblastoma. | |
| TW200631584A (en) | A medicament related to mirtazapine for the treatment of hot flush | |
| PL1865931T3 (pl) | Plaster przezskórny | |
| NO20092496L (no) | Ny terapeutisk anvendelse for behandling av leukemi | |
| NO20063619L (no) | Diarylmetylpiperazinderivater, fremstilling og anvendelse derav | |
| MY140538A (en) | Substituted n-acyl-2-aminothiazoles |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |